Evidence map›Paper›PMID 39273550›Full record

ArticleInternational journal of molecular sciences2024

The Preliminary Analysis of Flavonoids in the Petals of

Xiaoqian Shi, Yizhen Wang, Su Gong, Xianlun Liu, Ming Tang, Jing Tang, Wei Sun, Yin Yi, Jiyi Gong, Ximin Zhang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Metabolomic and Transcriptomic Responses ofPlants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Identification of the Antagonistic FungusJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Isolation and Identification ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoqian ShiSchool of Life Sciences, Guizhou Normal University, Guiyang 550025, China.
Yizhen WangSchool of Life Sciences, Guizhou Normal University, Guiyang 550025, China.
Su GongSchool of Life Sciences, Guizhou Normal University, Guiyang 550025, China.
Xianlun LiuSchool of Life Sciences, Guizhou Normal University, Guiyang 550025, China.
Ming TangKey Laboratory of State Forestry Administration on Biodiversity Conservation in Karst Area of Southwest, Guizhou Normal University, Guiyang 550025, China.ORCID 0000-0002-2068-0782
Jing TangKey Laboratory of Plant Physiology and Development Regulation, Guizhou Normal University, Guiyang 550025, China.ORCID 0000-0002-5854-7645
Wei SunKey Laboratory of Plant Physiology and Development Regulation, Guizhou Normal University, Guiyang 550025, China.
Yin YiKey Laboratory of State Forestry Administration on Biodiversity Conservation in Karst Area of Southwest, Guizhou Normal University, Guiyang 550025, China.
Jiyi GongKey Laboratory of State Forestry Administration on Biodiversity Conservation in Karst Area of Southwest, Guizhou Normal University, Guiyang 550025, China.
Ximin ZhangSchool of Life Sciences, Guizhou Normal University, Guiyang 550025, China.ORCID 0000-0002-8376-6882

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The petal blight disease of alpine Rhododendron severely impacts the ornamental and economic values of Rhododendron. Plant secondary metabolites play a crucial role in resisting pathogenic fungi, yet research on metabolites in alpine Rhododendron petals that confer resistance to pathogenic fungi is limited. In the present study, the secondary metabolites in

Indexed as

FlavonoidsFlowersPlant DiseasesRhododendronAntifungal AgentsAscomycotaDisease ResistanceMetabolomicsTandem Mass SpectrometryAntifungal AgentsFlavonoidsalpine rhododendronflavonoidsfungusnaringeninpetal blight disease

Identifiers

PMID39273550
PMCPMC11394826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.